Dimed SA Distribuidora De Medicamentos (PNVL3)

Currency in BRL

9.28

+0.07(+0.76%)

Closed·23/07

Fair Value

Unlock Value

Day's Range

9.07

9.28

52 wk Range

7.83

10.97

PNVL3 Financial Summary

A brief financial summary of Dimed SA Distribuidora De Medicamentos as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio13.54

Price/Book1.04

Debt / Equity98.14%

Return on Equity7.98%

Dividend Yield3.80%

EBITDA367.87M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

2,819.11

3,225.41

3,990.48

4,461.02

4,942.46

Gross Profit

aa.aa

831.01

994.64

1,245.04

1,381.56

1,578.4

Operating Income

aa.aa

93.39

102.78

137.84

161.89

197.33

Net Income

aa.aa

56.15

79.43

86.35

92.91

105.51

Balance Sheet

Total Assets

aa.aa

2,194.37

2,381.06

2,733.13

3,077.47

3,377.45

Total Current Liabilities

aa.aa

677.72

814.97

1,008.23

1,134.41

1,184.66

Total Equity

aa.aa

1,010.64

1,046.2

1,108.16

1,173.42

1,234.71

Cash Flow

Levered Free Cash Flow

aa.aa

2.23

-69.32

-54.03

39.68

-64.78

Cash from Operations

aa.aa

130.98

131.18

205.48

296.62

224.45

Cash from Investing

aa.aa

-390.5

14.91

-131.09

-196.56

-55.69

Cash from Financing

aa.aa

318.19

-221.76

-103.12

-97.83

-116.71

Net Change in Cash

aa.aa

58.67

-75.67

-28.72

2.24

52.04

* In Millions of BRL (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 0.65%

Dividend Yield

3.77%

Industry Median 1.06%

Annualised payout

0.35

Paid unevenly

5-Years Growth

Growth Streak

Unlock

Analyst Ratings

4 Buy

1 Hold

0 Sell

Ratings:

5 analysts

Overall Consensus

Buy

Analysts 12-Month Price Target:

Average 11.90

(+28.23% Upside)

Earnings

Latest Release

May 07, 2025

EPS / Forecast

0.17 / --

Revenue / Forecast

1.29B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Dimed's earnings for the latest quarter?

The Dimed EPS (TTM) is 0.65. Dimed reported sales of 1,258.69, net income of 25.47, and EPS of 0.17 for the latest quarter.

What was Dimed's net income for the latest quarter?

Dimed's net income for the latest quarter was 25.47.

How did Dimed's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,346.77 in the previous quarter to 1,258.69 in the latest quarter, and net income moved from 30.97 to 25.47 compared to the previous quarter.

What is Dimed's net profit margin on a TTM basis?

Dimed's trailing twelve months (TTM) net profit margin is 2.13%.

How does Dimed's debt to equity ratio compare to industry standards?

Dimed's total debt-to-equity ratio is 98.14%.

What is Dimed's return on investment on a TTM basis?

Dimed's trailing twelve months (TTM) return on investment (ROI) is 7.98%.

Did Dimed gain or lose cash last quarter?

In the latest quarter, Dimed's net change in cash was 8.23 million.

What were Dimed's total assets and liabilities in the latest quarter?

As of the latest quarter, Dimed reported total assets of 3,175.00 million and total liabilities of 940.75 million.

How has Dimed's total revenue grown this year?

Dimed's total revenue was 1,346.77 in the previous quarter and 1,258.69 in the latest quarter.

What is Dimed's gross margin on a TTM basis?

Dimed's trailing twelve months (TTM) gross margin is 31.90%.

What was Dimed's revenue per share for the latest quarter?

Dimed's revenue per share for the latest quarter was 99.89.

NSE 30

4,867.47

+3.88

+0.08%

NSE All Share

132,557.44

+105.70

+0.08%

US 30

44,891.80

-118.5

-0.26%

US 500

6,365.00

+6.0

+0.09%

FTSE 100

9,061.49

+37.68

+0.42%

DAX

24,240.82

+198.92

+0.83%

South Africa Top 40

92,457.00

+866.71

+0.95%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	28.50	+3.64%	98.62M
UBA	46.70	0.00%	18.21M
Oando Plc	52.20	+0.77%	16.21M
Guaranty Trust Holding	94.00	+0.21%	12.18M
Lafarge Africa	120.55	-4.33%	8.33M
Dangote Cement	490.00	+0.20%	2.66M
Aradel Holdings	502.00	+0.40%	2.45M

Name	Last	Chg. %	Vol.
Academy Press	7.70	+10.00%	2.13M
Initiates	13.34	+9.98%	2.11M
Ikeja	21.000	+9.95%	762.28K
Nigerian Enamelware PLC	24.55	+9.84%	239.53K
Nahco	117.000	+9.65%	2.53M
International Energy Insurance	2.38	+8.18%	3.16M
Cornerst	4.50	+7.40%	5.15M

Name	Last	Chg. %	Vol.
Austin Laz	2.34	-10.00%	289.11K
Tripple Gee and Co	3.89	-9.95%	159.73K
Omatek Ventures	1.30	-9.72%	4.30M
Daarcomm	0.75	-9.64%	4.73M
Guinea Insurance PLC	0.90	-9.09%	9.08M
Multverse	9.00	-9.09%	322.58K
Redstarex	11.75	-9.06%	434.41K

Trending Stocks

Name	Last	Chg. %	Vol.
Aradel Holdings	502.00	+0.40%	2.45M
Ellah Lakes	9.21	-6.97%	61.12M
Guaranty Trust Holding	94.00	+0.21%	12.18M
Access Holdings	28.50	+3.64%	98.62M
Dangote Sugar	60.00	+6.95%	6.08M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaa A	5,450.00	+37.06%	7,469.77
Aa A Aa	490.00	+26.14%	618.09
Aaaaaa Aaa Aaaaa	66.00	+22.27%	80.70
Aaaaa Aaaaaaa	400.00	+10.02%	440.08

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Dimed SA Distribuidora De Medicamentos (PNVL3)

PNVL3 Financial Summary

Key Ratios

Statements Highlights

Dividends

Analyst Ratings

Analysts 12-Month Price Target:

Earnings

FAQ

What were Dimed's earnings for the latest quarter?

What was Dimed's net income for the latest quarter?

How did Dimed's performance compare year-over-year in the latest quarter?

What is Dimed's net profit margin on a TTM basis?

How does Dimed's debt to equity ratio compare to industry standards?

What is Dimed's return on investment on a TTM basis?

Did Dimed gain or lose cash last quarter?

What were Dimed's total assets and liabilities in the latest quarter?

How has Dimed's total revenue grown this year?

What is Dimed's gross margin on a TTM basis?

What was Dimed's revenue per share for the latest quarter?

Trending Stocks